Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

Authors

Tshepiso Madihlaba (ORCID: https://orcid.org/0000-0003-1343-7757)
Andrea Szegedi (ORCID: https://orcid.org/0000-0003-2109-9014)
Kim Papp (ORCID: https://orcid.org/0000-0001-9557-3642)
Charles W Lynde (ORCID: https://orcid.org/0000-0001-9163-5463)
Simone Rubant
Mamitaro Ohtsuki (ORCID: https://orcid.org/0000-0001-7845-6698)
Paula Carolina Luna (ORCID: https://orcid.org/0000-0002-8002-4234)
Julia‐Tatjana Maul (ORCID: https://orcid.org/0000-0002-9914-1545)
Diamant Thaçi (ORCID: https://orcid.org/0000-0001-8513-550X)
Hongwei Wang (ORCID: https://orcid.org/0000-0003-2868-5112)
Ahmed M. Soliman (ORCID: https://orcid.org/0009-0008-8632-1396)
Christian Kaufmann (ORCID: https://orcid.org/0000-0003-1837-2374)
Doug Ashley

Institutions

University of Debrecen (HU)
Jichi Medical University (JP)
University of Toronto (CA)
University of Zurich (CH)
AbbVie (United States) (US)
Lynde Centre for Dermatology (CA)
University Hospital of Zurich (CH)
Probity Medical Research (CA)
Hospital Alemán (AR)
University of Lübeck (DE)

Publication Details

Journal: Dermatology and Therapy
Published: 2025-02-01
DOI: https://doi.org/10.1007/s13555-025-01342-0
Citations: 8
Primary Topic: Psoriasis: Treatment and Pathogenesis
Type: article
Field-Weighted Citation Impact: 6.38

Funders

AbbVie

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

Tshepiso Madihlaba, Andrea Szegedi, Kim Papp, Charles W Lynde et al.

Feb 1, 2025

8 citations

Dermatology and Therapy

Psoriasis: Treatment and Pathogenesis

6.38

article

Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months

Tshepiso Madihlaba, Andrea Szegedi, Kim Papp, Charles W Lynde, Simone Rubant, Mamitaro Ohtsuki, Paula Carolina Luna, Julia‐Tatjana Maul, Diamant Thaçi, Hongwei Wang, Ahmed M. Soliman, Christian Kaufmann, Doug Ashley

February 1, 2025article en

8 citations

Abstract

No abstract available for this paper.

Dermatology and TherapyVol. 15(2)

University of Debrecen (HU), Jichi Medical University (JP), University of Toronto (CA), University of Zurich (CH), AbbVie (United States) (US), Lynde Centre for Dermatology (CA), University Hospital of Zurich (CH), Probity Medical Research (CA), Hospital Alemán (AR), University of Lübeck (DE)

AbbVie

Openalex Percentile: Top 3%

Psoriasis: Treatment and Pathogenesis

6.38

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.